First, low levels of both TF and TD antibodies increased the risk for bladder cancer, for TF by a HR = 1.71, 95% CI: 1.12, 2.61 and for TD by a HR = 1.61, 95% CI: 1.05, 2.44. This evidence concerns the gene TF and urinary bladder cancer.